Compare BBNX & HQH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BBNX | HQH |
|---|---|---|
| Founded | 2015 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.0B |
| IPO Year | 2025 | N/A |
| Metric | BBNX | HQH |
|---|---|---|
| Price | $31.13 | $19.00 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 12 | 0 |
| Target Price | ★ $28.92 | N/A |
| AVG Volume (30 Days) | ★ 928.2K | 183.8K |
| Earning Date | 10-28-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 11.56% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.09 |
| Revenue | ★ $88,570,000.00 | N/A |
| Revenue This Year | $52.13 | N/A |
| Revenue Next Year | $36.16 | N/A |
| P/E Ratio | ★ N/A | $15.24 |
| Revenue Growth | ★ 67.01 | N/A |
| 52 Week Low | $8.89 | $14.31 |
| 52 Week High | $32.71 | $17.94 |
| Indicator | BBNX | HQH |
|---|---|---|
| Relative Strength Index (RSI) | 55.06 | 52.03 |
| Support Level | $28.36 | $18.39 |
| Resistance Level | $32.21 | $19.14 |
| Average True Range (ATR) | 1.66 | 0.34 |
| MACD | -0.18 | -0.03 |
| Stochastic Oscillator | 66.89 | 64.47 |
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.
abrdn Healthcare Investors Formerly Tekla Healthcare Investors is the United States based non-diversified closed-end management investment company. Its objective is to seek long-term capital appreciation by investing in securities of healthcare companies. In addition, the fund seeks to provide regular distribution of realized capital gains. The fund invests in the securities of public and private companies.